Category
CLSI C43-A2 – Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline-Second Edition, C43A2E
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.
This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.
Product Details
- Published:
- 03/01/2010
- ISBN(s):
- 1562387200
- File Size:
- 1 file , 2 MB
- Note:
- This product is unavailable in Russia, Belarus
Related products
-
CLSI VET03
$180.00$108.00Add to cartMethods for Antimicrobial Broth Dilution and Disk Diffusion Susceptibility Testing of Bacteria Isolated From Aquatic Animals, 2nd Edition, VET03Ed2E
Published by Publication Date Number of Pages CLSI 05/20/2020 122 -
CLSI VET04
$180.00$108.00Add to cartPerformance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals, 3rd Edition, VET04Ed3E
Published by Publication Date Number of Pages CLSI 05/20/2020 88 -
CLSI QMS22
$180.00$108.00Add to cartManagement of Paper-based and Electronic Laboratory Information, 1st Edition, QMS22Ed1E
Published by Publication Date Number of Pages CLSI 08/01/2018 78 -
CLSI VET06
$180.00$108.00Add to cartMethods for Antimicrobial Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria Isolated From Animals, 1st Edition, VET06Ed1E
Published by Publication Date Number of Pages CLSI 01/01/2017 114